Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension

Chinese Medical Journal

Volumn 119, Issue 20, 2006, Pages 1727-1733

  Zhang, Zhong Tao ^a   Jiang, Peng ^a   Wang, Yu ^a   Li, Jian She ^a   Xue, Jian Guo ^a   Zhou, Yan Zhong ^a   Yuan, Zhu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocyte growth factor; Hypertension; Portacaval shunt; Portal; Surgical

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYALURONIC ACID; INSULIN; LAMININ; SCATTER FACTOR; SODIUM CHLORIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CELL DAMAGE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAVENOUS CATHETER; LIVER; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MALE; MITOCHONDRION; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PORTOCAVAL SHUNT; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SCORING SYSTEM;

EID: 33750722410     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200610020-00010     Document Type: Article

References (28)

1. Weng YB, Wang Y, Li JS, Zhang ZT, Xue JG, Qu WK. The influence of side-to-side portacaval shunt plus enhancement of perfusion of hepatic artery on cirrhotic liver: an experimental study. Chin J Surg (Chin) 1998; 36: 487-490.
2. Capussotti L, Vergara V, Polastri R, Marucci MM, Borzari H, Fva C. A critical appraisal of the small-diameter portacaval H-graft. Am J Surg 1995; 170: 10-14.
3. Sarfeh IJ, Rypins EB, Mason GR. A systemic appraisal of portacaval H-graft diameters-clinical and hemodynamic perspectives. Ann Surg 1986; 204: 356-363.
4. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. Myocardial protection from infarction by endogenous and exogenous hepatocyte growth factor. J Clin Invest 2000; 106: 1511-1519.
5. James R, Bradshaw RA. Polypeptide growth factors. Annu Rev Biochem 1984; 53: 259-292.
6. Protor E, Chartamra K. Standardized micronodular cirrhosis in the rat. Eur Surg Res 1984; 16: 182-186.
7. Bradbury P, Gordon KC. Connective tissue and stain. In: Bancroft JD, Stevens A, eds. Theory and practice of histological techniques. New York: Churchill Livingston Press; 1990: 119-142.
8. Zhu JX, Wang BE, Wang TL. The preventive and therapeutic effect of Chinese caterpilar fungus on hepatic fibrosis caused by experimental immunologic injury. Chin J Digest (Chin) 1994; 14: 333-335.
9. Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Lou CL, et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002; 15: 1374-1380.
10. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982; 83: 1183-1190.
11. Hernandez-Munoz R, Diaz-Munoz M, Suarez J, Chagoya de Sanchez V. Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology 1990; 12: 242-248.
12. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
13. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443.
14. Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992; 15: 5-11.
15. Yoshinaga Y, Matsuno Y, Fujita S, Nakamura T, Kikychi M, Shimosato Y, et al. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 1993; 84: 1150-1158.
16. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997; 239: 639-644.
17. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001; 59: 2023-2038.
18. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Hepatocyte growth factor abrogates Fas-induced lethal liver apoptosis in mice. Biochem Biophys Res Commun 1998; 244: 683-690.
19. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T. Myocardial protection from infarction by endogenous and exogenous hepatocyte growth factor. J Clin Invest 2000; 106: 1511-1519.
20. Date I, Takagi N, Takagi K, Kago T, Matsumoto K, Nakamura T, et al. Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats. J Neurosci Res 2004; 78: 442-534.
21. Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci 2002; 22: 6537-6548.
22. Pinzani MN. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther 1995; 66: 387-412.
23. Niki T, Pekny M, Hellemans K, Bleser PD, Berg KV, Vaeyens F, et al. Class IV intermediate filament protein nestin is inducedduring activation of rat hepatic stellate cells. Hepatology 1999; 29: 520-527.
24. Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Muller E, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodeling interface in human cirrhosis. Hepatology 1999; 29: 1768-1778.
25. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835.
26. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995; 118: 643-649.
27. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med 1999; 5: 226-230.
28. Michalopoulos GK, Zarnegar R. Hepatocyte growth factor. Hepatology 1992; 15: 149-155.